Photo taken from Fadi Haddad/X
Sep 8, 2024, 08:21
Fadi Haddad: Update from SOHO24 – Pregnancy in CML
Fadi Haddad shared on X:
“Update from SOHO24
Pregnancy in CML
IFN safe any time during pregnancy, slow acting, used to control counts
Avoid TKIs during 1st trimester
IMA and NIL overall safe after week 16-18
DAS contraindicated
Little data on BOS, PON, ASC”
Source: Fadi Haddad/X
More posts featuring Fadi Haddad on oncodaily.ccom
Fadi Haddad is an Assistant Professor in the Department of Leukemia, Division of Cancer Medicine, at the The University of Texas MD Anderson Cancer Center. He earned his MD from Saint Joseph University, Beirut. He completed his residencyin Hematology/Oncology, from Hotel Dieu de France Hospital.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14